Compare YARW & MGF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | YARW | MGF |
|---|---|---|
| Founded | 2021 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.6M | 93.2M |
| IPO Year | 2017 | N/A |
| Metric | YARW | MGF |
|---|---|---|
| Price | $18.90 | $13.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $57.00 | N/A |
| AVG Volume (30 Days) | ★ 95.8K | 40.0K |
| Earning Date | 11-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.64% |
| EPS Growth | ★ 33.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.24 | $2.64 |
| 52 Week High | $44.28 | $13.99 |
| Indicator | YARW | MGF |
|---|---|---|
| Relative Strength Index (RSI) | 32.49 | 93.81 |
| Support Level | $18.24 | $2.84 |
| Resistance Level | $32.89 | N/A |
| Average True Range (ATR) | 1.95 | 0.15 |
| MACD | -0.02 | 1.26 |
| Stochastic Oscillator | 13.55 | 94.89 |
Yarrow Bioscience Inc is a clinical-stage biopharmaceutical company focused on developing biotherapeutics for autoimmune thyroid diseases. Its flagship product candidate, YB-101 (also known as GenSci098), is a humanized, monoclonal antibody targeting the thyroid-stimulating hormone receptor, which Yarrow plans to develop for the treatment of Graves' disease (GD) and potentially thyroid eye disease (TED). The company has one reportable segment relating to the research and development of its research programs, GD and TED.
Aberdeen Government Markets Income Fund is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income, but it may also consider capital appreciation.